Andrology pp 279-321 | Cite as

Disorders of Erection, Cohabitation, and Ejaculation

  • Hermann van AhlenEmail author
  • Sabine Kliesch


Congenital or acquired anatomical abnormalities of the penis may interfere with cohabitation and normal deposition of semen. These congenital anatomical variations especially include abnormal position of the urethral meatus (hypospadias/epispadias), but also, penile deviations due to induratio penis plastica (IPP; Peyronie's disease) which represents the most common clinical problem.


Erectile Dysfunction Corpus Cavernosa Premature Ejaculation Vasoactive Substance Tunica Albuginea 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Altinkilic B, Hauck EW, Weidner W (2004) Evaluation of penile perfusion by color-coded duplex sonography in the management of erectile dysfunction. World J Urol 22:361–364PubMedGoogle Scholar
  2. American Urological Association (AUA) (2005) Management of erectile dysfunction. Website guidelines
  3. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Juenemann KP (2008) Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU 101:1279–1283Google Scholar
  4. Behre HM (2004) Testosterone and erection. In: Nieschlag E, Behre HM (eds) Testosterone — action, deficiency and substitution, 3rd edn. Cambridge University Press, Cambridge, pp 333–346Google Scholar
  5. Bella AJ, Perelman MA, Brant WO, Lue TF (2007) Peyronie's disease (CME). J Sex Med 4:1527–1538PubMedGoogle Scholar
  6. Biagiotti G, Cavallini G (2001) Acetyl-L-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report. BJU Int 88:63–67PubMedGoogle Scholar
  7. Blount MA, Beasley A, Zoraghi R, Sekhar KR, Bessay EP, Francis SH, Corbin JD (2004) Binding of tritiated sildenafil, tadalafil or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Mol Pharmacol 66:144–152PubMedGoogle Scholar
  8. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U (2000) Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res 12:305–311PubMedGoogle Scholar
  9. Briganti A, Salonia A, Gallina A, Chun FKH, Karakiewicz PI, Graefen M, Huland H, Rigatti P, Montorsi F (2007) Management of erectile dysfunction after radical prostatectomy in 2007. World J Urol 25:143–148PubMedGoogle Scholar
  10. Brock G, Tu LM, Linet OI (2001) Return of spontaneous erections during long term intracavernosal alprostadil (Caverject) treatment. Urology 57:536–541PubMedGoogle Scholar
  11. Burnett AL (2004) Novel nitric oxide signaling mechanisms regulate the erectile response. Int J Impot Res 16(1): S15–S19PubMedGoogle Scholar
  12. Carson CC, Rajfer J, Eardley I, Carrier S, Denne JS, Walker DJ, Shen W, Cordell WH (2004) The efficacy and safety of tada-lafil: an update. BJU Int 93:1276–1281PubMedGoogle Scholar
  13. Colpi GM, Fanciullacci F, Aydos K, Grugnetti C (1991) Effectiveness mechanism of chlomipramine by neurophysi-ological tests in subjects with true premature ejaculation. Andrologia 23:45–47PubMedGoogle Scholar
  14. Cookson MS, Nadig PW (1993) Long-term results with vacuum constriction device. J Urol 149:290–294PubMedGoogle Scholar
  15. Davis–Joseph B, Tiefer L, Melman A (1995) Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology 45:498–502PubMedGoogle Scholar
  16. Del Popolo G, Li Marzi V, Mondaini N (2002) Time/duration effectiveness of sildenafil versus tadalafil in the treatment of erectile dysfunction in male spinal-cord injured patients. Spinal Cord 42:643–648Google Scholar
  17. Denil J, Ohl DA, McGuire EJ, Jonas U (1992) Treatment of ane– jaculation with electroejaculation. Acta Urol Belg 60:15–25PubMedGoogle Scholar
  18. Derouet H, Zehl U (1990) Die Behandlung der erektilen Dys-funktion mittels Vakuumsaugpumpen (EHS). Urologe A 32:312–315Google Scholar
  19. Dettmers C, Ahlen H van, Faust H, Fatepour D, Tackmann W (1994) Evaluation of erectile dysfunction with the sympathetic skin response in comparison to bulbocavernosus reflex and somatosensory evoked potentials of the pudendal nerve. Electromyogr clin Neurophysiol 34:437–444PubMedGoogle Scholar
  20. Droggin D, Shabsigh R, Anastasiadis G (2005) Antibiotic coating reduces penile prosthesis infection. J Sex Med 2:565–568PubMedGoogle Scholar
  21. Ernst E, Pittler MH (1998) Yohimbine for erectile dysfunction: a systematic review and meta—analysis of randomized clinical trials. J Urol 159:433–436PubMedGoogle Scholar
  22. Fabbri A, Jannini EA, Gnessi L, Moretti C, Ulisse S, Franzese A, Lazzari R, Fraioli F, Frajese G, Isidori A (1989) Endorphins in male impotence: evidence for naltrexone stimulation of erectile activity in patient therapy. Psychoneu-roendocrinology 14:103–111Google Scholar
  23. FDA (2007) FDA proposes new warnings about suicidal thinking, behavior in young adults who take andidepressant medications. FDA news: http//
  24. Feldmann HA, Goldstein I, Hatzichriston DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psycho-social correlates: results of the Massachusetts Male Aging Study. J Urol 151:54–61Google Scholar
  25. Goldstein I, Lue TF, Padma-Nathan H for the Sildenafil Study Group (1998) Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 338:1397–1404PubMedGoogle Scholar
  26. Golijanin D, Singer E, Davis R, Bhatt S, Seftel A, Dogra V (2007) Doppler evaluation of erectile dysfunction. Int J Impot Res 19:37–48PubMedGoogle Scholar
  27. Gorkin L, Hvidsten K, Sobel RE, Siegel R (2006) Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy. Int J Clin Pract 60:500–503PubMedGoogle Scholar
  28. Greenstein A, Plymate SR, Katz PG (1995) Visually stimulated erection in castrated men. J Urol 153:650–652PubMedGoogle Scholar
  29. Grein U, Noll F, Schreiter F (1989) Behandlung der erektilen Dysfunktion mit Penisprothesen. Urologe A 28:266–270PubMedGoogle Scholar
  30. Hartmann U, Langer D (1993) Combination of psychosexual therapy and intrapenile injections in the treatment of erectile dysfunctions: rationale and predictors of outcome. J Sex Educ Ther 19:1–12Google Scholar
  31. Hatzichristou DG, Suenz de Tejada I, Kupferman S, Namburi S, Pescatore ES, Udelson D, Goldstein I (1995) In vivo assessment of trabecular smooth muscle tone, its application in pharmaco–cavernosometry and analysis of intracavernous pressure determinents. J Urol 153:1126–1135PubMedGoogle Scholar
  32. Hauck EW, Diemer T, Weidner W (2006) Induratio penis plas-tica. Urologe 45:243–259Google Scholar
  33. Hauri D (1984) Therapiemöglichkeiten bei der vaskulär bed-ingten erektilen Impotenz. Akt Urol 15:350–354Google Scholar
  34. Heaton JPW, Morales A, Adams MA, Johnston B, El-Radhidy R (1995) Recovery of erectile function by the oral administration of apomorphine. Urology 45:200–206PubMedGoogle Scholar
  35. Hellstrom WJG (2007) Current safety and tolerability issues in men with erectile dysfunction receiving PDE-5 inhibitors. Int J Clin Pract 61:1547–1554PubMedGoogle Scholar
  36. Jackson G, Montorsi P, Cheitlin M (2006a) Cardiovascular safety of sidenafil citrate (Viagra): an updated perspective. Urology 68:47–60PubMedGoogle Scholar
  37. Jackson G, Rosen RC, Kloner RA, Kostis JB (2006b) The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 3:28–36PubMedGoogle Scholar
  38. Jardin A, Wagner G, Khoury S, Giuliano F, Padma-Nathan H, Rosen R (eds) (2000) Erectile dysfunction. Health Publication Ltd., Plymouth, UK, pp 711–726Google Scholar
  39. Kamischke A, Nieschlag E (1999) Treatment of retrograde ejaculation and anejaculation. Hum Reprod Update 5:448–474PubMedGoogle Scholar
  40. Kaneko S, Bradley WA (1987) Penile electrodiagnosis: penile peripheral innervation. Urology 30:210–213PubMedGoogle Scholar
  41. Kelami A (1985) Congenital penile deviation and straightening of the penis using the Nesbit–Kelami technique. Urol Int 40:267–268PubMedGoogle Scholar
  42. Kim ED, McVary KT (1995a) Long–term follow up of treatment of Peyronie's disease with plaque incision, carbon dioxide laser plaque ablation and placement of a deep dorsal vein patch graft. J Urol 153:1843–1846PubMedGoogle Scholar
  43. Kim ED, McVary KT (1995b) Long–term results with penile vein ligation for venogenic impotence. J Urol 153:655–658PubMedGoogle Scholar
  44. Kim SC, Seo KK (1998) Efficacy and safety of fluoxetine, sertra-line and clomipramine in patients with premature ejaculation: a double blind, placebo controlled study. J Urol 159:425–427PubMedGoogle Scholar
  45. Kloner R (1999) Safety of sildenafil citrate in men with erectile dysfunction taking multiple antihypertensive agents. Am J Hypertens 12:37Google Scholar
  46. Kloner R, Jackson G, Hutter AM, Mittleman MA, Chan M, Warner M, Costigan TM, Vail GM (2006) Cardiovascular safety update of tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of tadalafil with as needed, three times-per-week or once-a-day dosing. Am J Cardiol 97:1778–1784PubMedGoogle Scholar
  47. Kloner RA, Speakman M (2002) Erectile dysfunction and atherosclerosis. Curr Atheroscler Rep 5:397–401Google Scholar
  48. Klotz T, Bauer RJ, Rohde G (2002) Effect of renal impairment on the single-dose pharmacokinetics of vardenafil 20 mg, a selective PDE-5 inhibitor, for the treatment of erectile dysfunction. Pharmacotherapy 22:418Google Scholar
  49. Kostis JB, Jackson G, Rosen R, Barrett-Connor E, Billups K, Burnett AL, Carson III C, Cheitlin M, Debusk R, Fonseca V, Ganz P, Goldstein I, Guay A, Hatzichristou D, Hollander JE, Hutter A, Katz S, Kloner RA, Mittleman M, Montorsi F, Montorsi P, Nehra A, Sadovsky R, Shabsigh R (2005) Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol 96:313–321PubMedGoogle Scholar
  50. Lavoisier P, Proulx J, Courtois F, De CF (1989) Bulbocavernosus reflex: its validity as a diagnostic test of neurogenic impotence. J Urol 141:311–314PubMedGoogle Scholar
  51. Lawrence S, Madakasira S (1992) Evaluation and treatment of premature ejaculation: a critical review. Int J Psychiatry Med 22:77–97Google Scholar
  52. Lemourt OM, Filgueiras LE, Rodriguez BA, Gonzalez OE, Bordonado R (1998) Clinical evaluation of the use of propoleum in Peyronie's disease. Arch Esp Urol 51:171–176Google Scholar
  53. Lue TF, Tanagho EA (1987) Physiology of erection and pharmacological management of impotence. J Urol 137:829–836PubMedGoogle Scholar
  54. Masters WH, Johnson VE (1970) Human sexual inadequacy. Little, Brown, Boston, MAGoogle Scholar
  55. McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M, Xin ZC (2004) Disorders of orgasm and ejaculation in men. J Sex Med 1:58–65PubMedGoogle Scholar
  56. Mittleman MA, Maclure M, Glasser DB (2005) Evaluation of acute rsik for myocardial infarction in men treated with sildenafil citrate. Am J Cardiol 96:443–446PubMedGoogle Scholar
  57. Moldings GJ, van Ahlen H, Göthert M (1992) Modulation of noradrenaline release in human corpus cavernosum by pre-synaptic protaglandin receptors. Int J Impotence Res 4:19–25Google Scholar
  58. Montorsi F, Guazzoni G, Strambi LF (1997) Recovery of spontaneous erectile function after nerve-sparing retropubic radical prostatectomywith and without early intracavernous injections of alprostadil: results of a prospective, randomised trial. J Urol 158:1408–1410PubMedGoogle Scholar
  59. Montorsi F, Brock G, Lee J, Shapiro J, van Poppel H, Graefen M, Stief C (2008) Effect of nightly versus on-demand vard-enafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 54:924–931PubMedGoogle Scholar
  60. Montorsi P, Ravagnani PM, Galli S, Rotatori F, Briganti A, Salonia A, Rigatti P, Montorsi F (2005) The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 96:19M–23M.PubMedGoogle Scholar
  61. Morales A, Condra M, Reid K (1990) The role of nocturnal penile tumescence monitoring in the diagnosis of impotence: a review. J Urol 143:441–446PubMedGoogle Scholar
  62. Mulhull J, Montorsi F (2006) Evaluating preference trials of oral phosphodiesterase 5 inhibitors for erectile dysfunction. Eur Urol 49:30–37Google Scholar
  63. Mulhull J, Land S, Parker M, Waters WB, Flanigan RC (2005) The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2:532–545Google Scholar
  64. Mulhull JP, Simmons J (2007) Assessment of comparative treatment satisfaction with sildenafil citrate and penile injection therapy in patients responding to both. BJU Int 100:1313–1316Google Scholar
  65. Nathalie A, Olianas R, Fisch M (2008) Penile implantation in Europe: successes and complications with 253 implants in Italy and Germany. J Sex Med 5:1503–1512Google Scholar
  66. Nesbit RM (1954) The surgical treatment of of congenital chordee without hypospadias. J Urol 72:1178–1180PubMedGoogle Scholar
  67. Oates CP, Pickard RS, Powell PH, Murthy LNS, Whittingham TAW (1995) The use of duplex ultrasound in the assessment of arterial supply to the penis in vasculogenic impotence. J Urol 153:354–357PubMedGoogle Scholar
  68. Padma-Nathan H (2006) Sildenafil Citrate (Viagra) treatment for erectile dysfunction: an updated profile of response and effectiveness. Int J Impot Res 18:423–431PubMedGoogle Scholar
  69. Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE, Norwood PC, Peterson CA, Shabsigh R, Tam PY (1997) Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med 336:1–7PubMedGoogle Scholar
  70. Patterson B, Bedding A, Hayley J, Payne C, Mitschell M (2002) Dose normalised pharmacokinetics of tadalafil administered as a single dose to healthy volunteers. Eur Urol Suppl. 1:152, Abstract 600Google Scholar
  71. Pickering TG, Shepherd AM, Puddey I (2004) Sildenafil citrate for erectile dysfunction in men receiving multiple antihyper-tensive agents: a randomized controlled trial. Am J Hypertens 14:70–73Google Scholar
  72. Porst H (1990) Diagnostic use and side effects of vasoactive drugs — a report on over 2,100 patients with erectile failure. Int J Impotence Res 2(2):222–223Google Scholar
  73. Porst H, van Ahlen H (1989) Drug-induced priapism — a report of experiences in 101 cases. Urologe 28:84–87PubMedGoogle Scholar
  74. Porst H, Weller S (1989) Vasoaktive Substanzen bei erektiler Dysfunktion (ED) — Ergebnisse einer Umfrage und Litera-turübersicht. Urologe B 29:10–14Google Scholar
  75. Porst H, Ahlen H van, Köster O, Schlolaut KH (1988a) Vergleich von Papaverin-induzierter Doppler-Sonographie und Angiog-raphie in der Diagnostik der erektilen Dysfunktion. Urologe A 27:8–13PubMedGoogle Scholar
  76. Porst H, Tackmann W, Ahlen H van (1988b) Neurophysiological investigations in potent and impotent men. Assessment of bulbocavernosus reflex latencies and somatosensory evoked potentials. Br J Urol 61:445–450PubMedGoogle Scholar
  77. Porst H, Rajfer J, Casabé A, Feldman R, Ralph D, Vieiralves LF, Esler A, Wolka AM, Klise SR (2008) Long-term safety and efficacy of tadalafil 5 mg dosed once daily in men with erectile dysfunction. J Sex Med 5:2160–2169PubMedGoogle Scholar
  78. Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R, Miloslavsky M, Kell S (2006) Efficacy and tol-erability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double blind, randomised controlled trials. Lancet 368:929–937PubMedGoogle Scholar
  79. Rajfer J, Aliotta PJ, Steidle CP, Fitch III WP, Zhao Y, Yu A (2007) Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double–blind, placebo-controlled study in the US. Int J Impot Res 19:95–103PubMedGoogle Scholar
  80. Ralph D, Eardley I, Kell P, Dean J, Hackett G, Collins O, Edwards D (2007) Improvement in erectile function on vard-enafil treatment correlates with treatment satisfaction in both patients and their partners. BJU Int 100:130–136PubMedGoogle Scholar
  81. Rhee E, Osborn A, Witt M (1995) The correlation of cavernous systolic occlusion pressure with peak velocity flow using color duplex doppler ultrasound. J Urol 153:358–360PubMedGoogle Scholar
  82. Robert A, Kloner RA, Mohan P, Norenberg C (2002) Cardiovascular safety of vardenafil, a potent, highly selective PDE-5 inhibitor in patients with erectile dysfunction: an analysis of five placebo-controlled clinical trials. Pharmacol Ther 22:1371–1375Google Scholar
  83. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M (2004) Men's Attitudes to Life Events and Sexuality (MALES) Study. I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin 20:607–617PubMedGoogle Scholar
  84. Rosen RC, Fisher WA, Beneke M, Homering M, Evers T (2007) The COUPLES-project: a pooled analysis of patient and partner treatment satisfaction scale (TSS) outcomes following vardenafil treatment. BJU Int 99:849–859PubMedGoogle Scholar
  85. Rosenberg MT (2007) Diagnosis and managment of erectile dysfunction in the primary care setting. Int J Clin Pract 61:1198–1208PubMedGoogle Scholar
  86. Rubio-Aurioles E, Porst H, Eardley I, Goldstein I (2006) Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomised, double-blind, pooled crossover study. J Sex Med 3:1037–1049PubMedGoogle Scholar
  87. Safarinejad MR (2004) Therapeutic effects of colchicines in the management of Peyronie's disease: a randomized double-blind, placebo-controlled study. Int J Impot Res 16:238–243PubMedGoogle Scholar
  88. Safarinejad MR (2007) Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo controlled, fixed dose, randomised study. J Clin Psychopharmacol 27:444–450PubMedGoogle Scholar
  89. Safarinejad MR, Hosseini SY, Kolahi AA (2007) Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. J Urol 178:1398–1403PubMedGoogle Scholar
  90. Sairam K, Kulinskaya E, Boustead GB, Hanbury DC, McNicholas TA (2001) Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction. BJU Int 88:68–71PubMedGoogle Scholar
  91. Salem EA, Wilson SK, Bissada NK, Delk JR, Hellstrom WJ, Cleves MA (2008) Tramadol HCL has promise in on-demand use to treat premature ejaculation. J Sex Med 5:188–193PubMedGoogle Scholar
  92. Scott FB, Bradley WE, Timm GW (1973) Management of erectile impotence: use of implantable inflatable prosthesis. Urology 2:80–82PubMedGoogle Scholar
  93. Seftel A (2004) Phosphodiesterase type 5 inhibitor differentiation based on selectivity, pharmacokinetic and efficacy pro-files. Clin Cardiol 27:14–19Google Scholar
  94. Small MP, Carrion HH (1975) A new penile prosthesis for treating impotence. Contemp Surg 7:29–33Google Scholar
  95. Sohn M, Sikora RR, Bohndorf KK, Wein B, Zabelberg U, Jakse G (1992) Objective follow-up after penile revascularisation. Int J Impot Res 4:73–84Google Scholar
  96. Stanley EA, Rowland DL (2008) Identifying constructs and criteria for the diagnosis of premature ejaculation: implication for making errors of classification. BJU Int 102:708–712Google Scholar
  97. Stief CG (1993) Diagnostik und Therapie der erektilen Dysfunktion. Internist 34:767–774PubMedGoogle Scholar
  98. Teloken C, Rhoden EL, Grazziotin TM, Ros CT, Sogari PR, Souto CA (1999) Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol 162:2003–2005PubMedGoogle Scholar
  99. Valiquette L, Montorsi F, Auerbach S (2008) Vardenafil demonstrates first-dose success and reliability of penetration and maintenance of erection in men with erectile dysfunction – RELY-II. Can Urol Assoc J 2:187–195PubMedGoogle Scholar
  100. van Ahlen H, Peskar BA, Sticht G, Hertfelder HJ (1994) Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum. J Urol 151:1227–1230PubMedGoogle Scholar
  101. van Ahlen H, Piechota HJ, Kias HJ, Brennemann W, Klingmüller D (1995) Opiate antagonists in erectile dysfunction: a possible new treatment option. Eur Urol 28:246–250PubMedGoogle Scholar
  102. van Ahlen H, Wahle K, Kupper W, Yassin A, Reblin T, Neureither M (2005) Safety and efficacy of vardenafil, a selective phos-phodiesterase 5 inhibitor in patients with erectile dysfunction and arterial hypertension treated with multiple antihypertensives. J Sex Med 2:856–864PubMedGoogle Scholar
  103. Virag R, Zwang G, Dermange H, Legman M (1981) Vasculogenic impotence: a review of 92 cases with 54 surgical operations. Vasc Surg 15:9–15Google Scholar
  104. Vogt HJ, Brandl P, Kockott G, Schmitz JR, Wiegand MH, Schadrack J (1997) Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonor-ganic erectile dysfunction. Int J Impot Res 9:155–161PubMedGoogle Scholar
  105. Wegner HEH, Andresen R, Knispel HH, Banzer D, Miller K (1995) Evaluation of penile arteries with color-coded duplex sonography: prevalence and possible therapeutic implications of connections between dorsal and cavernous arteries in impotent men. J Urol 153:1469–1471PubMedGoogle Scholar
  106. Weidner W, Hauck EW, Schnitker J (2005) Peyronie's disease study group of andrological group of German urologists. Eur Urol 47:530–535PubMedGoogle Scholar
  107. Wilson SK, Delk J, Neeb A, Cleves M (2006) Long term survival of inflatable penile prostheses: single surgical group experience with 2,384 first time implants spanning two decades. J Urol 174:1304Google Scholar
  108. Zumbé J, Porst H, Sommer F, Grohmann W, Beneke M, Ulbrich E (2008) Comparable efficacy of once-daily versus on–demand vardenafil in men with mild-to-moderate erectile dysfunction: findings of the RESTORE Study. Eur Urol 54:204–212PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  1. 1.Clinic for Urology and Pediatric UrologyKlinikum Osnabrück GmbHOsnabrückGermany
  2. 2.Centre of Reproductive Medicine and Andrology of the UniversityMünsterGermany

Personalised recommendations